EE517 Cost-Effectiveness Analysis of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Greece
Abstract
Authors
M. Karaiskou A. Avgitidou Z. Vostitsanou M. Batsi G. Bungey T. Prawitz B. Peter P. Stafylas